These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 19829016

  • 1. Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy.
    McDonald L, Lee GR, Degooyer TE, McDonald D, Canning P, Kelso EJ, McDermott BJ, Stitt AW.
    Ophthalmic Res; 2010; 43(2):99-107. PubMed ID: 19829016
    [Abstract] [Full Text] [Related]

  • 2. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
    Spiers JP, Kelso EJ, Siah WF, Edge G, Song G, McDermott BJ, Hennessy M.
    J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats.
    Alrashdi SF, Deliyanti D, Wilkinson-Berka JL.
    Exp Eye Res; 2018 Nov; 176():1-9. PubMed ID: 29944850
    [Abstract] [Full Text] [Related]

  • 4. Diabetes-induced vascular dysfunction in the retina: role of endothelins.
    Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S.
    Diabetologia; 1999 Oct; 42(10):1228-34. PubMed ID: 10525664
    [Abstract] [Full Text] [Related]

  • 5. Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats.
    Evans T, Xi Deng D, Mukherjee K, Downey D, Chakrabarti S.
    Diabetes Res Clin Pract; 2000 May; 48(2):75-85. PubMed ID: 10802144
    [Abstract] [Full Text] [Related]

  • 6. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni.
    Su W, Dai DZ, Liu HR, Na T, Dai Y.
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859
    [Abstract] [Full Text] [Related]

  • 7. Significance of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats: renal and hemodynamic effects of endothelin receptor antagonists.
    Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N, Bauer C, Koppenhagen K.
    J Cardiovasc Pharmacol; 1995 Dec; 26 Suppl 3():S470-2. PubMed ID: 8587449
    [Abstract] [Full Text] [Related]

  • 8. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP.
    Nakamura K, Sasaki S, Moriguchi J, Morimoto S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, Nakagawa M.
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590
    [Abstract] [Full Text] [Related]

  • 9. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
    Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N, Bauer C, Koppenhagen K, Neumayer HH, Distler A.
    Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
    [Abstract] [Full Text] [Related]

  • 10. Renal endothelin ET(A)/ET(B) receptor imbalance differentiates salt-sensitive from salt-resistant spontaneous hypertension.
    Rothermund L, Luckert S, Kossmehl P, Paul M, Kreutz R.
    Hypertension; 2001 Feb; 37(2):275-80. PubMed ID: 11230285
    [Abstract] [Full Text] [Related]

  • 11. Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats.
    Girchev R, Bäcker A, Markova P, Kramer HJ.
    Kidney Int; 2004 Mar; 65(3):982-9. PubMed ID: 14871418
    [Abstract] [Full Text] [Related]

  • 12. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats.
    Evans T, Deng DX, Chen S, Chakrabarti S.
    Diabetes; 2000 Apr; 49(4):662-6. PubMed ID: 10871206
    [Abstract] [Full Text] [Related]

  • 13. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Battistini B, Ayach B, Molez S, Blouin A, Jeng AY.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
    [Abstract] [Full Text] [Related]

  • 14. Torcetrapib impairs endothelial function in hypertension.
    Simic B, Hermann M, Shaw SG, Bigler L, Stalder U, Dörries C, Besler C, Lüscher TF, Ruschitzka F.
    Eur Heart J; 2012 Jul; 33(13):1615-24. PubMed ID: 21920972
    [Abstract] [Full Text] [Related]

  • 15. [The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].
    Gu Y, Chen J, Yang H, Zhu W, Lin F, Zhu C, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Jan 10; 82(1):10-3. PubMed ID: 11953118
    [Abstract] [Full Text] [Related]

  • 16. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
    Chen J, Gu Y, Lin F, Yang H, Zhu W, Ma J, Lin S.
    Chin Med J (Engl); 2002 Jul 10; 115(7):972-8. PubMed ID: 12150723
    [Abstract] [Full Text] [Related]

  • 17. Vasoactivity of retinal veins: A potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO).
    Kida T, Flammer J, Oku H, Konieczka K, Morishita S, Horie T, Ikeda T.
    Exp Eye Res; 2018 Nov 10; 176():207-209. PubMed ID: 30025919
    [Abstract] [Full Text] [Related]

  • 18. ETA receptor-mediated Ca2+ signaling in thin descending limbs of Henle's loop: impairment in genetic hypertension.
    Bailey MA, Haton C, Orea V, Sassard J, Bailly C, Unwin RJ, Imbert-Teboul M.
    Kidney Int; 2003 Apr 10; 63(4):1276-84. PubMed ID: 12631344
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T, Ohta H, Okada M, Kawai N, Nakao R, Siegl PK, Kobayashi T, Miyauchi T, Nishikibe M.
    J Cardiovasc Pharmacol; 2000 Nov 10; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J, Vuolteenaho O, Marttila M, Ruskoaho H.
    Circulation; 1997 Nov 04; 96(9):3053-62. PubMed ID: 9386175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.